Consequently, expression of lncRNA-SARCC was found to be reduced in ccRCC and metastatic ccRCC compared to surrounding non-tumour and non-metastatic tissues, and this reduction correlated with a poorer prognosis in ccRCC patients. This evidence concerns the gene P2RY1 and nonpapillary renal cell carcinoma.